Herein, we report the generation of two types of CCD patient-derived iPSCs, one with a heterozygous loss of DNA-binding activity of RUNX2 and another which supposedly alters nuclear localization of the RUNX2 protein. Here, RUNX2 is linked to cleidocranial dysplasia 1.